Media Coverage Joni Henderson 10/8/24 Joni Henderson 10/8/24 Washington Post: Alzheimer’s patients and their families hear a new word: Progress Read More Joni Henderson 9/26/24 Joni Henderson 9/26/24 Medical Device Network: C2N receives funding for Alzheimer’s disease testing platform Read More Joni Henderson 8/13/24 Joni Henderson 8/13/24 NIH Research Matters: Accurate blood test for Alzheimer’s disease Read More Joni Henderson 8/7/24 Joni Henderson 8/7/24 360Dx: C2N Diagnostics and Unilabs Ink Deal to Sell Precivity Alzheimer’s Dx in Europe, Other Geographies Read More Joni Henderson 7/28/24 Joni Henderson 7/28/24 USA Today: How a new blood test technology could change Alzheimer’s treatment forever Read More Joni Henderson 7/28/24 Joni Henderson 7/28/24 St. Louis Post Dispatch: A St. Louis firm races to diagnose Alzheimer’s faster Read More Joni Henderson 5/2/24 Joni Henderson 5/2/24 The Clinical Trial Vanguard: C2N Diagnostics partners with Precivity™ Alzheimer’s Blood Test Expansion in Japan Read More Joni Henderson 3/7/24 Joni Henderson 3/7/24 Fierce Biotech: Eisai to drop up to $15M on C2N Diagnostics to boost the reach of Alzheimer's disease blood tests Read More Joni Henderson 2/23/24 Joni Henderson 2/23/24 Fierce Biotech: Study shows a front-line Alzheimer’s blood test could be as accurate as spinal fluid exams Read More Joni Henderson 2/8/24 Joni Henderson 2/8/24 360Dx: Alzheimer’s Biomarker Research Pushing Plasma P-Tau217 to the Fore Read More Joni Henderson 1/25/24 Joni Henderson 1/25/24 ALFORUM: AD Blood Tests are Here. Now, Let’s Grapple With How to Use Them Read More Joni Henderson 1/11/24 Joni Henderson 1/11/24 NPR: Blood tests can help diagnose Alzheimer’s - if they’re accurate enough. Not all are Read More Joni Henderson 11/8/23 Joni Henderson 11/8/23 Medical Device News: C2N’s Precivity blood biomarker test shows promise in Alzheimer’s screening Read More Joni Henderson 10/26/23 Joni Henderson 10/26/23 Medscape: Novel Tau Blood Biomarker Shows Promise Read More Joni Henderson 10/25/23 Joni Henderson 10/25/23 Proactive: BioVie says blinded data points to hopeful Alzheimer’s treatment potential Read More Joni Henderson 10/25/23 Joni Henderson 10/25/23 genomeweb: C2N Diagnostics MTBR-tau Read More Joni Henderson 10/25/23 Joni Henderson 10/25/23 Healio: Participation in digital cognitive test, biomarker assays linked to AD study enrollment Read More Joni Henderson 8/23/23 Joni Henderson 8/23/23 Fierce Biotech: C₂N Diagnostics launches revamped Alzheimer's blood test Read More Joni Henderson 8/18/23 Joni Henderson 8/18/23 Medical Device Network: C₂N launches new PrecivityAD® blood test Read More Joni Henderson 8/14/23 Joni Henderson 8/14/23 Alzheimer’s News Today: PrecivityAD® test for Alzheimer’s guided clinical decision-making Read More Older Posts
Joni Henderson 10/8/24 Joni Henderson 10/8/24 Washington Post: Alzheimer’s patients and their families hear a new word: Progress Read More
Joni Henderson 9/26/24 Joni Henderson 9/26/24 Medical Device Network: C2N receives funding for Alzheimer’s disease testing platform Read More
Joni Henderson 8/13/24 Joni Henderson 8/13/24 NIH Research Matters: Accurate blood test for Alzheimer’s disease Read More
Joni Henderson 8/7/24 Joni Henderson 8/7/24 360Dx: C2N Diagnostics and Unilabs Ink Deal to Sell Precivity Alzheimer’s Dx in Europe, Other Geographies Read More
Joni Henderson 7/28/24 Joni Henderson 7/28/24 USA Today: How a new blood test technology could change Alzheimer’s treatment forever Read More
Joni Henderson 7/28/24 Joni Henderson 7/28/24 St. Louis Post Dispatch: A St. Louis firm races to diagnose Alzheimer’s faster Read More
Joni Henderson 5/2/24 Joni Henderson 5/2/24 The Clinical Trial Vanguard: C2N Diagnostics partners with Precivity™ Alzheimer’s Blood Test Expansion in Japan Read More
Joni Henderson 3/7/24 Joni Henderson 3/7/24 Fierce Biotech: Eisai to drop up to $15M on C2N Diagnostics to boost the reach of Alzheimer's disease blood tests Read More
Joni Henderson 2/23/24 Joni Henderson 2/23/24 Fierce Biotech: Study shows a front-line Alzheimer’s blood test could be as accurate as spinal fluid exams Read More
Joni Henderson 2/8/24 Joni Henderson 2/8/24 360Dx: Alzheimer’s Biomarker Research Pushing Plasma P-Tau217 to the Fore Read More
Joni Henderson 1/25/24 Joni Henderson 1/25/24 ALFORUM: AD Blood Tests are Here. Now, Let’s Grapple With How to Use Them Read More
Joni Henderson 1/11/24 Joni Henderson 1/11/24 NPR: Blood tests can help diagnose Alzheimer’s - if they’re accurate enough. Not all are Read More
Joni Henderson 11/8/23 Joni Henderson 11/8/23 Medical Device News: C2N’s Precivity blood biomarker test shows promise in Alzheimer’s screening Read More
Joni Henderson 10/26/23 Joni Henderson 10/26/23 Medscape: Novel Tau Blood Biomarker Shows Promise Read More
Joni Henderson 10/25/23 Joni Henderson 10/25/23 Proactive: BioVie says blinded data points to hopeful Alzheimer’s treatment potential Read More
Joni Henderson 10/25/23 Joni Henderson 10/25/23 Healio: Participation in digital cognitive test, biomarker assays linked to AD study enrollment Read More
Joni Henderson 8/23/23 Joni Henderson 8/23/23 Fierce Biotech: C₂N Diagnostics launches revamped Alzheimer's blood test Read More
Joni Henderson 8/18/23 Joni Henderson 8/18/23 Medical Device Network: C₂N launches new PrecivityAD® blood test Read More
Joni Henderson 8/14/23 Joni Henderson 8/14/23 Alzheimer’s News Today: PrecivityAD® test for Alzheimer’s guided clinical decision-making Read More
